Wang Y - Search Results

1

Chemotherapy-induced executioner caspase activation increases breast cancer malignancy through epigenetic de-repression of CDH12.

Wang Y, Wang R, Liu X, Liu M, Sun L, Pan X, Hu H, Jiang B, Zou Y, Liu Q, Gong Y, Wang M, Sun G. Wang Y, et al. Among authors: wang m, wang r. Oncogenesis. 2023 Jun 24;12(1):34. doi: 10.1038/s41389-023-00479-x. Oncogenesis. 2023. PMID: 37355711 Free PMC article.

2

CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer.

Li Y, Hu H, Wang Y, Fan Y, Yang Y, Guo B, Xie X, Lian J, Jiang B, Han B, Wang Y, Shao C, Gong Y. Li Y, et al. Among authors: wang y. Oncogenesis. 2020 Feb 13;9(2):20. doi: 10.1038/s41389-020-0206-3. Oncogenesis. 2020. PMID: 32054830 Free PMC article.

3

CUL4B renders breast cancer cells tamoxifen-resistant via miR-32-5p/ER-α36 axis.

Wang Y, Pan X, Li Y, Wang R, Yang Y, Jiang B, Sun G, Shao C, Wang M, Gong Y. Wang Y, et al. Among authors: wang m, wang r. J Pathol. 2021 Jun;254(2):185-198. doi: 10.1002/path.5657. Epub 2021 Apr 9. J Pathol. 2021. PMID: 33638154

4

Knockdown of ER-α36 expression inhibits glioma proliferation, invasion and epithelial-to-mesenchymal transition.

Zhao B, Ye X, Yang Y, Wang Y, Wang R, Pan X, Wang M. Zhao B, et al. Among authors: wang y, wang m, wang r. Anat Rec (Hoboken). 2022 Feb;305(2):321-332. doi: 10.1002/ar.24723. Epub 2021 Aug 11. Anat Rec (Hoboken). 2022. PMID: 34331393 Free article.

5

Anastasis enhances metastasis and chemoresistance of colorectal cancer cells through upregulating cIAP2/NFκB signaling.

Wang R, Wang Y, Liu X, Liu M, Sun L, Pan X, Hu H, Jiang B, Zou Y, Liu Q, Gong Y, Wang M, Sun G. Wang R, et al. Among authors: wang y, wang m. Cell Death Dis. 2023 Jun 30;14(6):388. doi: 10.1038/s41419-023-05916-8. Cell Death Dis. 2023. PMID: 37391410 Free PMC article.

6

CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression.

Gong Q, Wang Y, Zhu K, Bai X, Feng T, Sun G, Wang M, Pan X, Qin C. Gong Q, et al. Among authors: wang y, wang m. Biochem Biophys Res Commun. 2023 Oct 8;676:58-65. doi: 10.1016/j.bbrc.2023.07.037. Epub 2023 Jul 18. Biochem Biophys Res Commun. 2023. PMID: 37487438

7

CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression.

Gong Q, Wang Y, Zhu K, Bai X, Feng T, Sun G, Wang M, Pan X, Qin C. Gong Q, et al. Among authors: wang y, wang m. Biochem Biophys Res Commun. 2024 Jan 8;691:149381. doi: 10.1016/j.bbrc.2023.149381. Epub 2023 Dec 26. Biochem Biophys Res Commun. 2024. PMID: 38151418 No abstract available.

8

Enhanced Apc^Min/+ adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells.

Guo B, Zheng Y, Fan Y, Yang Y, Wang Y, Qin L, An Y, Xu X, Zhang X, Sun G, Dou H, Shao C, Gong Y, Jiang B, Hu H. Guo B, et al. Among authors: wang y. Neoplasia. 2024 Jul;53:101005. doi: 10.1016/j.neo.2024.101005. Epub 2024 May 17. Neoplasia. 2024. PMID: 38761506 Free PMC article.

9

Overexpressing Bcl-2 enhances murine chimeric antigen receptor T cell therapy against solid tumor.

Wang X, Liu G, Shi X, Wang Y, Jiang B, Liu W, Dai A, Zhang X, Yu F. Wang X, et al. Among authors: wang y. Hum Cell. 2024 Jul;37(4):1107-1119. doi: 10.1007/s13577-024-01066-x. Epub 2024 May 1. Hum Cell. 2024. PMID: 38691335

10

Synergistic effect of chimeric antigen receptor modified with Bcl-2 on enhanced solid tumour targeting.

Wang X, Liu G, Huan T, Wang Y, Jiang B, Liu W, Dai A, Zhang X, Yu F. Wang X, et al. Among authors: wang y. Hum Cell. 2024 Sep;37(5):1421-1433. doi: 10.1007/s13577-024-01088-5. Epub 2024 Jun 15. Hum Cell. 2024. PMID: 38878230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299,824 results

Search Page

Filters